Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 4
1998 2
1999 2
2000 3
2001 1
2002 1
2004 2
2005 1
2006 2
2008 5
2009 2
2010 3
2011 7
2012 4
2013 8
2014 13
2015 12
2016 6
2017 8
2018 10
2019 17
2020 14
2021 18
2022 19
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.
Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; HERO Study Investigators. Shore ND, et al. N Engl J Med. 2020 Jun 4;382(23):2187-2196. doi: 10.1056/NEJMoa2004325. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469183 Clinical Trial.
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.
Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, Volanis D, Cussenot O, Subiela Henríquez JD, de la Peña E, Pisano F, Pešl M, van der Heijden AG, Herdegen S, Zlotta AR, Hacek J, Calatrava A, Mannweiler S, Bosschieter J, Ashabere D, Haitel A, Côté JF, El Sheikh S, Lunelli L, Algaba F, Alemany I, Soria F, Runneboom W, Breyer J, Nieuwenhuijzen JA, Llorente C, Molinaro L, Hulsbergen-van de Kaa CA, Evert M, Kiemeney LALM, N'Dow J, Plass K, Čapoun O, Soukup V, Dominguez-Escrig JL, Cohen D, Palou J, Gontero P, Burger M, Zigeuner R, Mostafid AH, Shariat SF, Rouprêt M, Compérat EM, Babjuk M, van Rhijn BWG. Sylvester RJ, et al. Among authors: rubio briones j. Eur Urol. 2021 Apr;79(4):480-488. doi: 10.1016/j.eururo.2020.12.033. Epub 2021 Jan 6. Eur Urol. 2021. PMID: 33419683
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Lozano R, Castro E, Lopez-Campos F, Thorne H, Ramirez-Backhaus M, Aragon IM, Cendón-Florez Y, Gutierrez-Pecharroman A, Salles DC, Romero-Laorden N, Lorente D, González-Peramato P, Calatrava A, Alonso C, Anido U, Arévalo-Lobera S, Balmaña J, Chirivella I, Juan-Fita MJ, Llort G, Y Cajal TR, Almagro E, Alameda D, López-Casas PP, Herrera B, Mateo J, Pritchard CC, Antonarakis ES, Lotan TL, Rubio-Briones J, Sandhu S, Olmos D. Lozano R, et al. Among authors: rubio briones j. Eur J Cancer. 2023 May;185:105-118. doi: 10.1016/j.ejca.2023.02.022. Epub 2023 Mar 5. Eur J Cancer. 2023. PMID: 36972661
Urology and Web predictive resources.
Borque A, Espárrago M, Sánchez-Martín F, Rubio-Briones J, Esteban LM, Sanz G. Borque A, et al. Among authors: rubio briones j. Actas Urol Esp. 2014 Apr;38(3):141-2. doi: 10.1016/j.acuro.2013.12.009. Epub 2014 Feb 16. Actas Urol Esp. 2014. PMID: 24548476 English, Spanish. No abstract available.
miRNAs as biomarkers in prostate cancer.
Casanova-Salas I, Rubio-Briones J, Fernández-Serra A, López-Guerrero JA. Casanova-Salas I, et al. Among authors: rubio briones j. Clin Transl Oncol. 2012 Nov;14(11):803-11. doi: 10.1007/s12094-012-0877-0. Epub 2012 Jul 24. Clin Transl Oncol. 2012. PMID: 22855165 Review.
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Beijert IJ, Hentschel AE, Bründl J, Compérat EM, Plass K, Rodríguez O, Subiela Henríquez JD, Hernández V, de la Peña E, Alemany I, Turturica D, Pisano F, Soria F, Čapoun O, Bauerová L, Pešl M, Bruins HM, Runneboom W, Herdegen S, Breyer J, Brisuda A, Calatrava A, Rubio-Briones J, Seles M, Mannweiler S, Bosschieter J, Kusuma VRM, Ashabere D, Huebner N, Cotte J, Mertens LS, Claps F, Masson-Lecomte A, Liedberg F, Cohen D, Lunelli L, Cussenot O, El Sheikh S, Volanis D, Côté JF, Rouprêt M, Haitel A, Shariat SF, Mostafid AH, Nieuwenhuijzen JA, Zigeuner R, Dominguez-Escrig JL, Hacek J, Zlotta AR, Burger M, Evert M, Hulsbergen-van de Kaa CA, van der Heijden AG, Kiemeney LALM, Soukup V, Molinaro L, Gontero P, Llorente C, Algaba F, Palou J, N'Dow J, Ribal MJ, van der Kwast TH, Babjuk M, Sylvester RJ, van Rhijn BWG. Beijert IJ, et al. Among authors: rubio briones j. Eur Urol Oncol. 2023 Apr;6(2):214-221. doi: 10.1016/j.euo.2023.01.004. Epub 2023 Jan 18. Eur Urol Oncol. 2023. PMID: 36670042 Free article.
Liquid biopsy: possibilities and limitations in uro-oncology.
López-Guerrero JA, Pastor-Navarro B, Claramunt-Alonso R, García-Flores M, Rubio-Briones J. López-Guerrero JA, et al. Among authors: rubio briones j. Arch Esp Urol. 2022 Mar;75(2):203-214. Arch Esp Urol. 2022. PMID: 35332890 Free article. English, Spanish.
[Radical laparoscopic nephrectomy].
Rubio Briones J, Iborra Juan I, Casanova Ramón-Borja J, Solsona Narbón E. Rubio Briones J, et al. Actas Urol Esp. 2006 May;30(5):479-91. doi: 10.1016/s0210-4806(06)73485-4. Actas Urol Esp. 2006. PMID: 16884099 Review. Spanish.
Update and optimization of active surveillance in prostate cancer in 2021.
Rubio-Briones J, Pastor Navarro B, Esteban Escaño LM, Borque Fernando A. Rubio-Briones J, et al. Actas Urol Esp (Engl Ed). 2021 Jan-Feb;45(1):1-7. doi: 10.1016/j.acuro.2020.09.002. Epub 2020 Oct 16. Actas Urol Esp (Engl Ed). 2021. PMID: 33070989 Review. English, Spanish.
156 results